Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $95.32 Million |
|---|---|
| Enterprise Value | $88.01 Million |
| Earnings per Share | $-1.74 |
| Beta | 1.99 |
| Outstanding Shares | 30,749,894 |
| P/E Ratio | -10.79 |
|---|---|
| PEG | 47.44 |
| Price to Sales | 1.55 |
| Price to Book Ratio | -3.1 |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | -4.07 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | -0.07 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a de...
Stockcircle shows 6 open-market insider purchases for AVITA Medical in the last six months from SEC Form 4 reports by executives, directors, and other insiders.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.